Wellgistics Health (NASDAQ:WGRX) Announces Earnings Results

Wellgistics Health (NASDAQ:WGRX) released its earnings results on Friday. The company reported ($0.13) EPS for the quarter, Zacks reports. Wellgistics Health had a negative net margin of 228.17% and a negative return on equity of 1,617.25%.

Wellgistics Health Trading Up 14.3%

Shares of Wellgistics Health stock opened at $0.14 on Friday. The company has a quick ratio of 0.16, a current ratio of 0.39 and a debt-to-equity ratio of 1.86. The firm has a market cap of $12.29 million and a price-to-earnings ratio of -0.12. The business has a fifty day simple moving average of $0.28 and a 200-day simple moving average of $0.57. Wellgistics Health has a fifty-two week low of $0.11 and a fifty-two week high of $7.04.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Wellgistics Health in a report on Monday, December 29th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company presently has a consensus rating of “Sell”.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of WGRX. XTX Topco Ltd lifted its holdings in Wellgistics Health by 195.1% in the 4th quarter. XTX Topco Ltd now owns 106,087 shares of the company’s stock valued at $42,000 after acquiring an additional 70,137 shares during the last quarter. Geode Capital Management LLC grew its stake in shares of Wellgistics Health by 81.0% in the 4th quarter. Geode Capital Management LLC now owns 487,383 shares of the company’s stock worth $195,000 after purchasing an additional 218,170 shares during the last quarter. Finally, Raymond James Financial Inc. raised its holdings in shares of Wellgistics Health by 593.8% in the 3rd quarter. Raymond James Financial Inc. now owns 58,421 shares of the company’s stock worth $52,000 after purchasing an additional 50,000 shares in the last quarter.

Wellgistics Health Company Profile

Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services. We are focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.